tiprankstipranks
Viracta Therapeutics (VIRX)
NASDAQ:VIRX

Viracta Therapeutics (VIRX) Technical Analysis

807 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Viracta Therapeutics’s (VIRX) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Viracta Therapeutics is a Buy.
Viracta Therapeutics’s (VIRX) 20-Day exponential moving average is 0.97, while Viracta Therapeutics’s (VIRX) share price is $1.02, making it a Buy.
Viracta Therapeutics’s (VIRX) 50-Day exponential moving average is 0.83, while Viracta Therapeutics’s (VIRX) share price is $1.02, making it a Buy.

Viracta Therapeutics (VIRX) Pivot Points

Apr 15, 2024, 09:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.00
1.03
1.05
1.08
1.10
1.13
1.15
Fibonacci
1.03
1.04
1.06
1.08
1.10
1.11
1.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viracta Therapeutics (VIRX) Moving Averages

Apr 15, 2024, 09:06 PM
Period
Simple
Exponential
MA5
1.04Sell
1.05Sell
MA10
1.04Sell
1.03Sell
MA20
0.98Buy
0.97Buy
MA50
0.76Buy
0.83Buy
MA100
0.66Buy
0.79Buy
MA200
0.94Buy
0.98Buy
Viracta Therapeutics’s (VIRX) 10-Day exponential moving average is 1.03, while Viracta Therapeutics’s (VIRX) share price is $1.02, making it a Sell.
Viracta Therapeutics’s (VIRX) 100-Day exponential moving average is 0.79, while Viracta Therapeutics’s (VIRX) share price is $1.02, making it a Buy.
Viracta Therapeutics’s (VIRX) stock price is $1.02 and Viracta Therapeutics’s (VIRX) 50-day simple moving average is 0.76, creating a Buy signal.
Viracta Therapeutics’s (VIRX) stock price is $1.02 and Viracta Therapeutics’s (VIRX) 100-day simple moving average is 0.66, creating a Buy signal.
Viracta Therapeutics’s (VIRX) stock price is $1.02 and Viracta Therapeutics’s (VIRX) 200-day simple moving average is 0.94, creating a Buy signal.

Viracta Therapeutics (VIRX) Technical Indicators

Apr 15, 2024, 09:06 PM
Name
Value
Implied Action
RSI (14)
57.84
Neutral
STOCH (9,6)
52.45
Neutral
STOCHRSI (14)
67.58
Neutral
MACD (12,26)
0.08
Buy
ADX (14)
36.08
Neutral
Williams %R
-48.54
Buy
CCI (14)
48.06
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
49.63
Neutral
ROC
20.00
Buy
Viracta Therapeutics’s (VIRX) Relative Strength Index (RSI) is 57.84, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Trend Strength Indicator (ADX) is 36.08, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Commodity Channel Index (CCI) is 48.06, creating a Neutral signal.
Viracta Therapeutics’s (VIRX) Price Rate of Change (ROC) is 20.00, creating a Buy signal.

FAQ

Is VIRX a Buy, Hold, or Sell?
Based on VIRX’s technical indicators, VIRX is a Buy.
    What is VIRX’s RSI (14)?
    VIRX’s RSI (14) is 57.84, which suggests VIRX is a Neutral.
      What is VIRX’s MACD?
      VIRX’s MACD is 0.08, which suggests VIRX is a Buy.
        What is VIRX’s 5-day moving average?
        VIRX’s 5-day moving average is 1.04, which suggests VIRX is a Sell.
          What is VIRX’s 20-day moving average?
          VIRX 20-day moving average is 0.98, which suggests VIRX is a Buy.
            What is VIRX’s 50-day moving average?
            VIRX’s 50-day moving average is 0.76, which suggests VIRX is a Buy.
              What is VIRX’s 200-day moving average?
              VIRX’s 200-day moving average is 0.94, which suggests VIRX is a Buy.
                What is VIRX’s Williams % R (14)?
                VIRX’s Williams % R (14) is -48.54, which suggests VIRX is a Buy.
                  What is VIRX’s CCI (14)?
                  VIRX’s CCI (14) is 48.06, which suggests VIRX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis